Literature DB >> 12796799

Acute renal failure due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient.

K Mori1, T Yoshihara, Y Nishimura, M Uchida, K Katsura, Y Kawase, I Hatano, H Ishida, T Chiyonobu, Y Kasubuchi, A Morimoto, T Teramura, S Imashuku.   

Abstract

Management of post-transplant complications caused by severe adenoviral infection remains a major therapeutic challenge. A 17-year-old male who had undergone bone marrow transplantation for the treatment of acute lymphoblastic leukemia developed complete anuria following hemorrhagic cystitis 34 days after the transplant procedure. The computed tomogram scan revealed bilateral hydronephrosis, indicating acute renal failure because of obstructive uropathy. The emergency procedure of percutaneous nephrostomy caused massive bleeding in the left kidney, which eventually required a nephrectomy. Adenovirus-positive severe necrotizing tubulointerstitial nephritis was the histopathological diagnosis. Post-transplant acute renal failure because of hydronephrosis, which could be complicated by adenovirus-induced renal parenchymal disease, is of great concern and may cause significant problems with interventional treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12796799     DOI: 10.1038/sj.bmt.1704077

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

1.  Late presentation of adenovirus-induced hemorrhagic cystitis and ureteral obstruction in a kidney-pancreas transplant recipient.

Authors:  Jeffrey Klein; Michael Kuperman; Clinton Haley; Yousri Barri; Arun Chandrakantan; Bernard Fischbach; Larry Melton; Kim Rice; Muhammad Saim; Angelito Yango; Goran Klintmalm; Arthi Rajagopal
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

2.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  Tubulointerstitial nephritis: diagnosis, treatment, and monitoring.

Authors:  Emily Joyce; Paulina Glasner; Sarangarajan Ranganathan; Agnieszka Swiatecka-Urban
Journal:  Pediatr Nephrol       Date:  2016-05-07       Impact factor: 3.714

4.  [Ureteral stenosis following hematopoietic stem cell transplantation: A case report].

Authors:  G P Han; Y Y Xu; Z H Li; C Meng; H J Zhu; K L Yang; L Q Zhou; X S Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

Review 5.  Viruses and kidney disease: beyond HIV.

Authors:  Meryl Waldman; Vickie Marshall; Denise Whitby; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2008-11       Impact factor: 5.299

6.  Factors associated with calcium requirements after parathyroidectomy in chronic kidney disease patients.

Authors:  Yue Ding; Hongying Wang; Qiang Zou; Yiting Jin; Zijing Zhang; Junwen Huang
Journal:  Int Urol Nephrol       Date:  2017-12-01       Impact factor: 2.370

Review 7.  Clinical review: specific aspects of acute renal failure in cancer patients.

Authors:  Michael Darmon; Magali Ciroldi; Guillaume Thiery; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

8.  Adenovirus nephritis and obstructive uropathy in a renal transplant recipient: case report and literature review.

Authors:  Luiz M Kolankiewicz; James Pullman; Mark Raffeld; Jeffrey B Kopp; Daniel Glicklich
Journal:  NDT Plus       Date:  2010-03-14

Review 9.  Mini-review of kidney disease following hematopoietic stem cell transplant
.

Authors:  Ramy Sedhom; Daniel Sedhom; Edgar Jaimes
Journal:  Clin Nephrol       Date:  2018-06       Impact factor: 0.975

Review 10.  Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.

Authors:  Joseph P Lynch; Adriana E Kajon
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.